retatrutide skin benefits Retatrutide…The next evolution in weight loss and metabolic health What to Know About Retatrutide

Even though it's the same medication it is licensed for a slightly different context

Discussion In our present study, we identified the causal role of GLP-1R-based agonists in reducing the risk of MASLD and its metabolic risk factors, including HDL-C, TG, and ISI, partly independent of the weight-loss effect

Future GLP-1 trends: new drugs and therapies on the horizon The future of weight management may soon involve more than current GLP-1s: Amylin mimetics: These compounds mimic another satiety hormone and may complement GLP-1s. Mazdutide: A dual glucagon/GLP-1 agonist showing strong Phase 3 results and promising greater weight loss. Oral GLP-1s: Pills in development could improve convenience. Muscle-preserving combinations: Researchers are exploring co-therapies to prevent loss of lean mass during weight loss. Providers should prepare for a rapidly evolving landscape and educate patients about upcoming options. Key takeaways on GLP-1 trends for providers and patients Efficacy varies across drugs and doses

Hiking is terrible, but I think that's because of my heart rate and not because of muscle loss